Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin α2 chain gene

Neuromuscular Disorders

Volumn 13, Issue 3, 2003, Pages 216-222

  Besse, Sylvie ^a   Allamand, Valérie ^a   Vilquin, Jean Thomas ^a   Li, Zhenlin ^b   Poirier, Christophe ^c   Vignier, Nicolas ^a   Hori, Hisae ^d   Guénet, Jean Louis ^b   Guicheney, Pascale ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT PASTEUR   (France)

^d Tokyo Medical and Dental University   (Japan)

Author keywords

Animal model; Laminin 2 chain; Long terminal repeat; Muscular dystrophy; Retrotransposon; Skeletal muscle

Indexed keywords

COMPLEMENTARY DNA; LAMININ ALPHA2; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; IMMUNOHISTOLOGY; LONG TERMINAL REPEAT; MALE; MOUSE STRAIN; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RETROPOSON; SKELETAL MUSCLE;

EID: 0037374229     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-8966(02)00278-x     Document Type: Article

References (38)

1. Banker B.Q. The congenital muscular dystrophies. Engel A.G., Franzini-Amstrong C. Myology, 2. 2nd ed. 1994;1275-1289 McGraw-Hill, New York.
2. Fardeau M. Congenital myopathies. Mastaglia F.L., Detchant L.W.O. Skeletal muscle pathology. 2nd ed. 1992;237-281 Churchill Livingstone, Edinburgh.
3. Helbling-Leclerc A., Zhang X., Topaloglu H., et al. Mutations in the laminin α2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 11:1995;216-218.
4. Nissinen M., Helbling-Leclerc A., Zhang X., et al. Substitution of a conserved cysteine-996 in a cysteine-rich motif of the laminin α2-chain in congenital muscular dystrophy with partial deficiency of the protein. Am J Hum Genet. 58:1996;1177-1184.
5. Allamand V., Sunada Y., Salih M.A.M., et al. Mild congenital muscular dystrophy in two patients with an internally deleted laminin α2-chain. Hum Mol Genet. 6:1997;747-752.
6. Burgeson R.E., Chiquet M., Deutzmann R., et al. A new nomenclature for the laminins. Matrix Biol. 14:1994;209-211.
7. Michelson A.M., Russell E., Harman P.G. Dystrophia muscularis: a hereditary primary myopathy in the mouse. Proc Natl Acad Sci USA. 41:1955;1079-1084.
8. Meier H., Southard J.L. Muscular dystrophy in the mouse caused by an allele at the dy locus. Life Sci. 9:1970;137-144.
9. Arahata K., Hayashi Y.K., Koga R., et al. Laminin in animal models for muscular dystrophy: defect of laminin M in skeletal and cardiac muscles and peripheral nerve of the homozygous dystrophic dy/dy mice. Proc Jpn Acad. 69:1993;259-264.
10. Sunada Y., Bernier S.M., Kozak C.A., Yamada Y., Campbell K.P. Deficiency of merosin in dystrophic dy mice and genetic linkage of the laminin M chain gene to the dy locus. J Biol Chem. 269:1994;13729-13732.
11. Xu H., Christmas P., Wu X.-R., Wewer U.M., Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci USA. 91:1994;5572-5576.
12. Xu H., Wu X.R., Wewer U.M., Engvall E. Murine muscular dystrophy caused by a mutation in the laminin α2 (LAMA2) gene. Nat Genet. 8:1994;297-302.
13. 2J mice. Hum Mol Genet. 4:1995;1055-1061.
14. Miyagoe Y., Hanaoka K., Nonaka I., et al. Laminin a2 chain-null mutant mice by targeted disruption of the LAMA2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy. FEBS Lett. 415:1997;33-39.
15. Kuang W., Vachon P.H., Liu L., Loechel F., Wewer U.M., Engvall E. Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models. J Clin Invest. 102:1998;844-852.
16. Ehrig K., Leivo I., Argraves W.S., Ruoslahti E., Engvall E. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA. 87:1990;3264-3268.
17. Hori H., Kaa T., Mizuta T., Yamaguchu N., Liu Y., Nagai Y. Human laminin M chain: epitope analysis of its monoclonal antibodies by immunoscreening of cDNA clones and tissue expression. J Biochem. 116:1994;1212-1219.
18. Blin N., Stafford D.W. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res. 3:1976;2303-2308.
19. Dietrich W.F., Miller J., Steen R., et al. A comprehensive genetic map of the mouse genome. Nature. 380:1996;149-152.
20. Manly K.F. A Macintosh program for storage and analysis of experimental genetic mapping data. Mamm Gen. 4:1993;303-313.
21. Zhang X., Vuolteenaho R., Tryggvason K. Structure of the human laminin a2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem. 271:1996;27664-27669.
22. Totsuka T., Watanabe K. Some evidence for concurrent involvement of the fore- and hindleg muscles in murine muscular dystrophy. Jikken Dobutsu. 30:1981;465-470.
23. Meier H., MacPike A.D. Myopathies caused by three mutations of the mouse. J Hered. 68:1977;383-385.
24. Kazazian H.H.J., Wong C., Youssoufian H., Scott A.F., Phillips D.G., Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature. 332:1988;164-166.
25. Narita N., Nishio H., Kitoh Y., et al. Insertion of a 5′ truncated L1 element into the 3′ end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest. 91:1993;1862-1867.
26. Konda-Iida E., Saito K., Tanaka H., et al. Molecular genetic evidence of clinical heterogeneity in Fukuyama-type congenital muscular dystrophy. Hum Genet. 99:1997;427-432.
27. Kingsmore S.F., Giros B., Suh D., Bieniarz M., Caron M.G., Seldin M.F. Glycine receptor beta-subunit gene mutation in spastic mouse associated with LINE-1 element insertion. Nat Genet. 7:1994;143-148.
28. Mulhardt C., Fischer M., Gass P., et al. The spastic mouse: aberrant splicing of glycine receptor beta subunit mRNA caused by intronic insertion of L1 element. Neuron. 13:1994;1003-1015.
29. Kuff E.L., Feenstra A., Lueders K., et al. Intracisternal A-particle genes as movable elements in the mouse genome. Proc Natl Acad Sci USA. 80:1983;1992-1996.
30. Kuff E.L., Lueders K.K. The intracisternal A-particle gene family: structure and functional aspects. Adv Cancer Rev. 93:1988;183-276.
31. Cole M.D., Ono M., Huang R.C. Terminally redundant sequences in cellular intracisternal A-particle genes. J Virol. 38:1981;680-687.
32. Lueders K., Kuff E.L. Sequences associated with intracisternal A particles are reiterated in the mouse genome. Cell. 12:1977;963-972.
33. Lueders K., Kuff E.L. Intracisternal A-particle genes: identification in the genome of Mus musculus and comparison of multiple isolates from a mouse gene library. Proc Natl Acad Sci USA. 77:1980;3571-3575.
34. Ono M., Cole M.D., White A.T., Huang R.C. Sequence organization of cloned intracisternal A particle genes. Cell. 21:1980;465-473.
35. Hawley R.G., Shulman M.J., Murialdo H., Gibson D.M., Hozumi N. Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci USA. 79:1982;7425-7429.
36. Wu M., Rinchik E.M., Wilkinson E., Johnson D.K. Inherited somatic mosaicism caused by an intracisternal A particle insertion in the mouse tyrosinase gene. Proc Natl Acad Sci USA. 94:1997;890-894.
37. Johnson K.R., Cook S.A., Erway L.C., et al. Inner ear and kidney anomalies caused by IAP insertion in an intron of the Eya1 gene in a mouse model of BOR syndrome. Hum Mol Genet. 8:1999;645-653.
38. Colognato H., Yurchenco P.D. The laminin alpha2 expressed by dystrophic dy(2J) mice is defective in its ability to form polymers. Curr Biol. 9:1999;1327-1330.